|
 |
|
| Prostate Cancer therapies |
 |
| |
Prostate cancer is usually a slow-developing cancer and fairly common in older men in the USA and Europe, while practically unknown in Asia and developing countries in Africa and South America.
In fact, most prostate cancers never grow to the point where they cause symptoms, and most men with prostate cancer die of other causes before prostate cancer has an impact on their lives.
The average age at the time of diagnosis is 70. However, many men never know they have prostate cancer. Autopsy studies of Chinese, German, Israeli, Jamaican, Swedish, and Ugandan men who died of other causes have found prostate cancer in thirty percent of men in their 50s, and in eighty percent of men in their 70s.
The PSA screening test (Prostate Specific Antigens blood test) may detect these small cancers that will never become life threatening. PSA tests in these men may lead to OVER-DIAGNOSIS, including additional testing and treatment. Follow-up tests, such as prostate biopsies, a procedure that cuts tissue out with needles, cause pain, bleeding and infection. Prostate cancer treatments like chemotherapy and radiotherapy cause urinary incontinence and erectile dysfunction. Therefore, it is essential that the risks and benefits of allopathic diagnostic procedures and treatments be carefully considered before PSA screening.
Screening for prostate cancer is controversial, to say it mildly, it is clear that the benefits of screening do not outweigh the risks of follow-up diagnostic tests and cancer treatments.
Most medical societies have not found sufficient evidence to support routine screening for prostate cancer - but the American Urological Association supports annual screening and digital examination for men over 50 years old - and starting earlier for ´men at high risk (those with a family history of prostate cancer or African American men)´, this high risk is established through statistics that you may or may not believe in.
In the year 2005 there were an estimated 230,000 new cases of prostate cancer diagnosed and treated and 30,000 deaths attributed to prostate cancer in the USA. An estimated 20 million PSA tests are done per year in North America.
These figures may be interpreted and evaluated at your discretion.
What would happen if you double the amount of PSA tests?
Do you get double the amount of new cases, treatments and deaths?
What would happen if you half the amount of PSA tests?
Do you get half the amount of new cases, treatments and deaths?
What would happen if you eliminate PSA tests?
Does the level sink to an Asian level?
These questions are purely hypothetical but they may help you to decide what to do when you are diagnosed with prostate cancer. Fear is induced and you feel the urge to go for treatment. In that case you may want to look at an alternative to surgery, chemotherapy and radiotherapy.
This alternative is High Intensity Focus Ultrasound, HIFU. It was developed in France, a non invasive procedure that replaces surgery, chemotherapy and radiotherapy in Europe.
HIFU was licensed in 2000 in Europe and in 2003 in Canada as Canada accepts European clinical trials. HIFU is not available in the USA as European clinical trials are not accepted there.
Details of High Intensity Focus Ultrasound HIFU are on the menu to the left.
All the above are tools of the cancer industry that tells you that "the cause of cancer is unknown", but tell you that they are the only ones who know how to treat cancer.
Should you see a contradiction in those statements and remember that Otto Warburg, Max Planck Institute Berlin, received the Nobel prize for discovering the cause of cancer in 1931 already, you will have further alternatives.
The cause of most cancers is an incomplete metabolism caused by foods and chemicals that you cannot metabolize. Your humors become acidy and deprive your cells of oxygen.
Healthy cells feed on oxygen and cancerous cells on glucose. It is a process that can be reversed. This is a simplified explanation but to the point.
The point is that there are natural methods available that will prevent prostate cancer from ever developing. There are also natural ways to cure prostate cancer. These natural therapies help you to keep your prostate and your erectile function, these arguments alone make it worthwhile contemplating natural therapies.
Update:
Source: New England Journal of Medicine (10.1056/NEJMoa0810084) was published at NEJM.org on March 18, 2009.
Screening and Prostate Cancer Mortality in a randomized European Study.
Authors: Dr. Fritz H Schröder at al at the Erasmus Medical Center, P.O. Box 2040, Rotterdam 3000 CA, the Netherlands.
I extract the relevant data:
162,243 men between the ages of 55 and 69 years, split into Screening group and Control group. The study was initiated in the early 1990s. The primary outcome was the rate of death from prostate cancer. Mortality follow-up was identical for the two study groups and ended on December 31, 2006.
126,462 PSA tests were performed, average 2.1 per subject.
16.2% of all tests were positive.
85.8% of those had a biopsy.
75.9% of those = 13,308 men had a FALSE POSITIVE result.
8.2% = 5990 prostate cancers in Screening group.
4.8% = 4307 prostate cancers in Control group.
Gleason score of 6 or less:
72.2% in Screening group
54.8% in Control group
Gleason score of 7 or more:
27.8% in Screening group
42.2% in Control group
The ABSOLUTE DIFFERENCE between the Screening group and the
Control group was 0.71 prostate cancer death per 1000 men.
The authors conclude and I quote:
"The rate of overdiagnosis of prostate cancer (defined as the diagnosis in men who would not have clinical symptoms during their lifetime) has been estimated to be as high as 50% in the screening group.Consistent estimates of overdiagnosis (a third of cancers detected on screening) have also been obtained by identifying potentially indolent prostate cancers on the basis of clinical and pathological characteristics. Overdiagnosis and overtreatment are probably the most important adverse effects of prostate-cancer screening and are vastly more common than in screening for breast, colorectal, or cervical cancer."
These devastating results are not limited to Europe, the US reaches the same conclusions.
Dr. Thomas Stanley, Professor of Urology at Stanford University School of Medicine, recently stated at a medical conference:
“We need to recognize that PSA is no longer a marker for prostate cancer. We originally thought we were doing the right thing, but we’re now figuring out how we went wrong.
Indeed. We’ve long known that 70% of men with elevated PSAs turn out not to have cancer (a false positive)."
In one recent study, researchers followed 9,459 men who had annual PSA tests. Of this group, 2,950 had test results showing very healthy prostates. But when these “healthy” men underwent biopsies, an alarming 15% tested positive for cancer! Many had high-grade cancer. And the PSA test missed it in all of them!
And the incidence rate of "false negative" may be even higher as prostate biopsies are taken by random needle jabs into the gland. An average prostate has a volume of 40ml and an early cancer may cover 1 or 2ml. No matter how many sticks are made, there’s no way of knowing if cancer lurks outside the needle tract.
The needle tract, however, damages tissue. Not only is this procedure painful, but it can also lead to infection and influence the development of cancer.
The bottom line: You may have high PSA and no cancer at all, or you may have zero PSA but prostate cancer, possibly even high-grade prostate cancer. Subjecting yourself to biopsy is an unnecessary risk.
Listings are on merit. Therapists have a
proven track record of successful treatments.
Top ten listings are by invitation or online
application. Please enquire by email to
ceo(at)infoholix.net, Wilfrid Hartnagel.
Positions 11 upwards require a sponsorship
fee of GBP5.00/US$7.25 monthly.
Therapists in Developing Countries can get
listed for free, please enquire.
|
|
|
|
 |
1. Soon the media will blast the headline "New Super Drug for Advanced Prostate Cancer improves survival by a staggering 38%". It is awaiting FDA approval, and no doubt it will be approved.
It exceeds FDA standards that require a drug to work 5% (five) better than placebo.
A clinical trial indicates the Super Drug improves 3-year survival rate by 38%. To be excact, the placebo group had a median survival of 23 month versus the Super Drug group´s 31.7 month, the mathematical difference is 38% based on 23 and 27.5% when based on 31.7.
This clinical trial also reveals that "Median survival" was extented by 4.1 months.
The placebo group´s figure = 21.7 months and 25.8 months for the Super Drug.
No doubt you´ll be spending hundreds of thousands of dollars to live these extra 4.1 months.
It is actually more than 4.1 months if you were to compare with survival after conventional treatments with chemotherapy and radiotherapy. These rates drop to below 20 months. It is politically incorrect to quote these figures as they prove that it is the treatments that kill and not the cancer. Below 20 months is lower than 23 months for placebo.
This political incorrectness urges Big Pharma to compare with placebo and not compare with already licensed chemo and radio treatments. There is a SIMPLE LOGIC:
If conventional chemo and radio would work better than placebo the 25.8 months achievement would not make it a Super Drug. This fact alone proves that chemo and radio are way below 25.8 months.
You can extract data from SEER in US and Eurocare in Europe and conclude that figures for chemo and radio are well below 20 months, a long way below 20 months. So when your hospital seduces you with propaganda of 80% cure rates - start thinking.
Why would you want to opt for placebo or something that extends or decreases your lifespan for a few months compared to placebo?
Why don´t you opt for cure instead?
Prostate cancer is curable at any stage and has been curable for a long time.
Cures are not commercially viable compared to the huge profits achieved with conventional treatments propagated in the West.
I, Wilfrid Hartnagel, owner of infoholix.net, will coach you. Mouse-over email button to see my private email.
You can visit my blog via the wwww button
   |
 |
2. Prostate Cancer sufferers in USA.
Have you been diagnosed with early stage or advanced stage prostate cancer?
Or have you had radiotherapy already and have now reached the stage where salvage treatment is needed?
According to studies that the public is often not aware of, failure rates of radiotherapy are 50% at 2 years and 75% at 5 years.
In comparison, HIFU has a 98% prostate cancer specific survival rate, that´s a failure rate of 2%, in addition 69% are biochemically disease free at 7 years (yes, 7, not 2 or 5). I´ll be glad to send you a long term study as attachment.
Your physician may accompany you to a HIFU clinic, obtain HIFU tuition and take part in your HIFU treatment.
I shall arrange your HIFU treatment abroad.
|
|
|
|
|
| |
| Bookmark our site |
| Add infoholix.net to your favorities... |
|
|
